Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05019495 · ClinicalTrials.gov registry record · NA

Optimizing Tobacco Treatment Delivery for People Living With HIV

A NA study of HIV and Smoking, Cigarette, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
231
Enrollment target
1
Study location

NCT05019495 is a NA study of HIV and Smoking, Cigarette that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 231 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05019495, a NA study of HIV and Smoking, Cigarette, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
231 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate implementation outcomes to identify barriers and facilitators towards future implementation. Investigators hope to define best practices and optimize the delivery of smoking cessation interventions for people living with HIV.

Conditions Studied

Interventions

  • BEHAVIORAL PrOMOTE

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 231 participants
Start Date 2021-12-01
Est. Completion 2027-02-28
Phase NA

What the Registry Record Tells You About NCT05019495

The ClinicalTrials.gov registry entry for NCT05019495 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (47% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which PrOMOTE is the first listed.

NCT05019495 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT05019495 about?

NCT05019495 is a clinical study titled "Optimizing Tobacco Treatment Delivery for People Living With HIV". The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate impl...

What is the current status of trial NCT05019495?

This trial is currently recruiting. It is a NA study. The enrollment target is 231 participants. The study started on 2021-12-01. Estimated completion is 2027-02-28.

What conditions does trial NCT05019495 study?

This clinical trial studies the following conditions: HIV, Smoking, Cigarette.

What interventions are being tested in trial NCT05019495?

The interventions under investigation include: PrOMOTE (BEHAVIORAL).

Who is sponsoring clinical trial NCT05019495?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05019495 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.